hotspot -WSS

hotspot

author：explore 2025-10-01 18:07:58 - browse：7211

the Federal Trade Commission building and its brown sign — Adobe

A federal judge ordered Wednesday that Novant Health can move forward with its plan to buy two North Carolina hospitals, denying the Federal Trade Commission’s request for an injunction.

The FTC sued to block the deal in January, arguing that it would give Novant control of more than 65% of the region’s inpatient market. The case, one seeking to block nearby hospitals from merging and creating an even more powerful dominant player, is the FTC’s bread and butter. The agency has shied away from challenging cross-market and vertical mergers, but this one is right in its wheelhouse, which makes the setback surprising.

Under the deal, announced early last year, Novant would buy two hospitals in the same county from for-profit Community Health Systems for $320 million. The hospitals, Lake Norman Regional Medical Center and Davis Regional Medical Center, are only a 25-minute drive from one another. Davis Regional used to be a full-service hospital, but is now a psychiatric hospital. The deal also includes a group of 24 doctors, a majority interest in an endoscopy center, and a holding in a planned surgery center.

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — plus in-depth analysis, newsletters, premium events, and networking platform access.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： How to save PrEP access — and even expand it
Next article： This gene therapy has record $4.25 million price. It's saved children.

hotspot

WSS

'Patient friction coefficient' can gauge a clinical trial's patient burden

New clues to why women have higher risk of autoimmune disorders

6 surprising facts about sugar

6 surprising facts about sugar

With Wegovy coverage, Medicare patients may face high costs

6 surprising facts about sugar

knowledge

hotspot

This article is exclusive to STAT+ subscribers

Unlock this article — plus in-depth analysis, newsletters, premium events, and networking platform access.

hotspot

23andMe had bad news about my health. I wish a person had delivered it

Philips to halt sales of sleep apnea machines in U.S.

After affirmative action ruling, medical educators look to 'holistic review'

Wegovy leads to weight loss. Can it treat depression, too?

23andMe had bad news about my health. I wish a person had delivered it

Merck, Johnson & Johnson CEOs will testify on high drug prices

Hollywood unions extend contract negotiations for actors

6 surprising facts about sugar

Tori Bowie and the unacceptable rates of Black maternal death

Novo Nordisk to buy Cardior, building up pipeline of heart drugs

explore

Steward Health Care expansion into Malta flopped

Chinese researcher claims birth of first gene

How generative AI ratchets up security threats for health systems

Ibogaine psychedelic therapy for opioid addiction unlikely, official says

Readout Newsletter: Illumina, CRISPR, Regeneron

10 reasons why health care startups fail

leisure time

hotspot

focus

knowledge